International researchers have just published in the journal Nature Genetics, the results of a study that could lead to a significant improvement in the treatment of type 2 diabetes. Researchers have identified a gene called substrate of insulin receptor 1 (SRI1). Unlike other gene discovered to date, SRI1 not involved in the decreased production of insulin, but it decreases the effects of insulin in muscle, liver and fat. It thus influences how the body responds to insulin in the bloodstream. Diabetes Type 2 primarily affects adults over 40 years. In 60% of cases, they are overweight, but there are important genetic factors that increase the risk of developing this disease. Diabetes type 2 has a body resistance to insulin, the hormone produced by the pancreas that allows cells to absorb glucose and convert it into energy.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment